This article is best viewed in a PDF Format.
Rohto Dry Eye Relief (Figure 1) is a new alternative for the management of dry eyes, manufactured by The Mentholatum Company.
Rohto Dry Eye Relief (RDER) is a novel solution that contains a patented bi-polymer. Trade named HydraMed, this bi-polymer is formed from the cooperative interaction of two naturally occurring polysaccharides, hyaluronic acid (HA), and tamarind seed polysaccharide (TSP).1 The latter is a new polysaccharide to the UK, with muco-mimetic properties and is derived from the seed of the Tamarind tree. Table 1 shows the solution is available in multi-dose and, what the company describes as, a daily-dose unit (DDU). The DDU has a novel replaceable cap with data supporting the safety of its reuse within 12 hours.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here